New York, NY, United States of America

Ross L Cagan

This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Icahn School of Medicine at Mount Sinai, University of California. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ross L Cagan. Retrieved from https://idiyas.com/inventor/ross-l-cagan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ross L. Cagan

Introduction

Ross L. Cagan is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of kinase inhibitor compounds. With a total of 4 patents to his name, Cagan's work has the potential to impact the lives of many patients.

Latest Patents

Cagan's latest patents focus on kinase inhibitor compounds, compositions, and methods of treating cancer. The inventions relate to compounds having specific structures, including stereoisomers, pharmaceutically acceptable salts, oxides, or solvates. These compounds are designed to provide effective treatment options for cancer patients, showcasing Cagan's commitment to advancing medical science.

Career Highlights

Throughout his career, Ross L. Cagan has worked with esteemed institutions such as the Icahn School of Medicine at Mount Sinai and the University of California. His research has been instrumental in developing new therapeutic approaches to combat cancer, highlighting his expertise and dedication to the field.

Collaborations

Cagan has collaborated with notable colleagues, including Arvin C. Dar and Tirtha K. Das. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pursuit of medical advancements.

Conclusion

In summary, Ross L. Cagan is a distinguished inventor whose work in kinase inhibitor compounds has the potential to revolutionize cancer treatment. His contributions to the field, along with his collaborations and career achievements, underscore his importance in the realm of medical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…